Status:

UNKNOWN

Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Lead Sponsor:

Gynecologic Oncology Group

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Fallopian Tube Carcinoma

Primary Peritoneal Carcinoma

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This randomized clinical trial is studying two different symptom management programs to see how well they work compared with usual care in patients with recurrent or persistent ovarian cancer, fallopi...

Detailed Description

PRIMARY OBJECTIVE: I. Compare the efficacy of nurse-delivered WRITE Symptoms? and self-directed WRITE Symptoms? vs usual care interventions in improving target symptom representations (i.e., decrease...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Diagnosis of ovarian, fallopian tube, or primary peritoneal cancer that has recurred or persisted following primary therapy
  • Active disease or current treatment are not required
  • Must be experiencing ? 3 symptoms associated with ovarian cancer or cancer treatment, including, but not limited to, any of the following:
  • Abdominal bloating or cramping
  • Nausea, vomiting, or diarrhea
  • Constipation
  • Anorexia
  • Anxiety
  • Depression
  • Dizziness
  • Drowsiness
  • Dry mouth
  • Fatigue
  • Headaches
  • Hair loss
  • Hot flashes
  • Memory concerns
  • Mood swings
  • Mouth sores
  • Pain
  • Peripheral neuropathies
  • Sexuality concerns
  • Sleep disturbances
  • Shortness of breath
  • Skin rash or palmar-plantar erythrodysesthesia
  • Urinary problems
  • Weight gain or loss
  • GOG performance status 0-2
  • Able to read and write English
  • Access to computer and the Internet required
  • Concurrent treatment on other clinical trials allowed

Exclusion

    Key Trial Info

    Start Date :

    January 19 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    Estimated Enrollment :

    485 Patients enrolled

    Trial Details

    Trial ID

    NCT00958698

    Start Date

    January 19 2010

    Last Update

    March 12 2019

    Active Locations (144)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 36 (144 locations)

    1

    Gynecologic Oncology Group of Arizona

    Phoenix, Arizona, United States, 85012

    2

    Cedars Sinai Medical Center

    Los Angeles, California, United States, 90048

    3

    UCLA / Jonsson Comprehensive Cancer Center

    Los Angeles, California, United States, 90095

    4

    Palo Alto Medical Foundation-Gynecologic Oncology

    Mountain View, California, United States, 94040